Which leading coronavirus vaccine candidate looks best so far?
News & Analysis: AstraZeneca PLC
It depends on what you mean by "beat."
You may be surprised by just how global the reach is of these international companies.
The market woke up a little tired on Monday morning.
For the third time this month, a potential vaccine for the global scourge shows extremely strong results.
The numbers are close, but two players stand out at the moment.
If you don't want to take on a lot of risk, this big COVID-19 vaccine leader could be right up your alley.
Pfizer grabbed the spotlight when it released efficacy data from its phase 3 study earlier this week. But is it too late to get in on the action?
There's no question that the big drugmaker has plenty to offer investors. But is that enough?
AZN earnings call for the period ending September 30, 2020.